Atlas Trials

A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C

Clinical trial NCT00394277 · COMPLETED

Trial details

NCT number
NCT00394277
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2007-02-01
Primary completion
2009-04-01
Enrollment
1175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.